Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.

ANZ journal of surgery - 1 May 2007

Suthers Graeme K

Abstract excerpt

One of the primary purposes of genetic testing for mutations in the BRCA1 and BRCA2 genes in patients with familial breast/ovarian cancer has been to provide accurate advice to at-risk relatives. The provision of such advice has been hampered by a lack of appropriate data regarding the cancer risks. Chen and colleagues recently provided precise estimates of the relative risks of breast and ovarian cancer in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Australia
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genetic Counseling

Share to Heterozygote

Share to Ovarian Neoplasms

Source

Identifiers

PMID: 17497966
DOI: 10.1111/j.1445-2197.2007.04050.x

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cancer risks for Australian women with a BRCA1 or a BRCA2 mutation.PMID 17497966Read ↗

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.Semantic proximity Read ↗

Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.Semantic proximity Read ↗

Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Average age-specific cumulative risk of breast cancer according to type and site of germline mutations in BRCA1 and BRCA2 estimated from multiple-case breast cancer families attending Australian family cancer clinics.Semantic proximity Read ↗

Some public health issues in the current state of genetic testing for breast cancer in Australia.Semantic proximity Read ↗

Current perspectives on BRCA1- and BRCA2-associated breast cancers.Semantic proximity Read ↗

Prospective study of breast cancer risk for mutation negative women from BRCA1 or BRCA2 mutation positive families.Semantic proximity Read ↗

Absolute risk of breast cancer for Australian women with a family history.Semantic proximity Read ↗

Cancer risks among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Cancer risks for men with BRCA1/2 mutationsSemantic proximity Read ↗

Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.